A new era in life sciences software
The fine chemicals and biochemicals industries will evolve towards more digitally designed processes associating experiments, user know-how and mechanistic modeling
Marc-Olivier Simon, Aline Devoille
"Life sciences industries still use outdated tools and methodologies to develop, optimise and operate their (bio)molecule production processes. Ypso-Facto proposes to take a fresh look at the needs and expectations of this sector.
Digitalisation or digital transformation is ubiquitous in discussions, articles, conferences and white papers. There are so many promises from digital technologies that many companies are considering them a key focus for their business. Although at different stages and paces, this evolution is underway and the main question for an organisation has shifted from “Should we go digital?” to “How do we go digital?” Life science industries are no exception. They face major challenges such as molecule discovery or development of optimised and reliable manufacturing processes, both with increasingly stringent competition and regulatory frameworks. They could benefit considerably from digitalisation, but therein lies the rub.
Although in constant evolution – in particular, to integrate more and more artificial intelligence and machine learning – molecule discoverers have been using dedicated software programs for years for retrosynthetic analyses or molecular modelling, for instance.
However, as far as manufacturing process development and optimisation is concerned, there is a huge gap between users’ expectations and software offering [...]"
Read the full article online in Specialty Chemical Magazine or download your copy below.
Ypso-Facto is a service company helping industrial firms to develop, optimize and secure their chemical processes and bioprocesses.